Developing and validating the prediction model of intravesical recurrence for patients with upper urinary tract urothelial cell carcinoma after sugury

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021626

Enrollment

Unknown

Registered

2019-03-01

Start date

2019-03-01

Completion date

Unknown

Last updated

2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper urinary tract urothelial cell carcinoma

Interventions

recurrence group :none

unrecurrence group :none

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: The diagnosis of UTUC was confirmed by pathologic examination. All tumor stages were graded T1-T3, which had no adjacent organ invasion and lymph node metastasis

Exclusion criteria

Exclusion criteria: Patients who had distant metastasis (M1) or bilateral UTUC were excluded, and those who underwent neoadjuvant chemotherapy or who had other malignancies in the final pathologic reports were excluded

Design outcomes

Primary

Measure	Time frame
recurrence;	—

Countries

China

Contacts

Public ContactSong Bai

Department of Urology, ShengJing Hospital of China Medical University

baisongcmu@163.com+86 18940255568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026